EAM Investors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,696
Closed -$3.18M 344
2021
Q4
$3.18M Sell
9,696
-234
-2% -$73.5K 0.52% 46
2021
Q3
$3M Buy
+9,930
New +$2.82M 0.51% 50

Other funds holding MLAB

EAM Investors's MLAB Position: Q1 2022 in Review

EAM Investors sold out of Mesa Laboratories (MLAB) in Q1 2022, closing a stake of 9,696 shares — an estimated $3.18M sold.

EAM Investors first reported a position in MLAB in Q3 2021 and held it in 2 quarters. The position peaked at $3.18M in Q4 2021. 175 funds tracked by Wall St. Rank hold MLAB as of Q1 2022.

  • EAM Investors reported no remaining Mesa Laboratories position as of Q1 2022 after selling out during the quarter.
  • EAM Investors sold 9,696 Mesa Laboratories shares in Q1 2022, an estimated $3.18M.
  • EAM Investors first reported a position in Mesa Laboratories in Q3 2021 and held it in 2 quarters.
  • EAM Investors's Mesa Laboratories position peaked at $3.18M in Q4 2021.
  • 175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2022.

Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.